Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid symbols : Osur save search
InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School TestingThe rapid at-home COVID-19 test is authorized for ages 2 and up
Published: 2022-05-25 (Crawled : 16:00) - biospace.com/
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 4.43%
H: 0.0%
C: -8.07%
covid-19 inteliswab test authorized covid
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App
Published: 2022-01-31 (Crawled : 15:00) - biospace.com/
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.69%
H: 2.58%
C: 1.37%
covid-19 inteliswab fda covid intel report authorization test
OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test
Published: 2021-10-04 (Crawled : 16:00) - globenewswire.com
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 2.24%
H: 3.84%
C: -1.74%
covid defense test contract
OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver
Published: 2021-09-23 (Crawled : 13:15) - biospace.com/
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.54%
H: 2.31%
C: -0.62%
covid test research authorized clearance
Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications and Growth Factors to 2030
Published: 2021-08-06 (Crawled : 15:00) - prnewswire.com
WST | $372.04 -1.4% 0.0% 440K
|
Health Technology
|
| O: -0.71%
H: 1.44%
C: 1.15%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.85%
H: 0.15%
C: -0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 0.23%
C: -0.3%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.19%
H: 0.54%
C: -0.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: -2.24%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: -2.64%
covid drug growth device drug delivery liver
OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use
Published: 2021-06-07 (Crawled : 14:00) - globenewswire.com
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.43%
H: 5.79%
C: 3.75%
covid test merge authorized emergency use authorization
Global COVID-19 At-Home Testing Trends and Market Report 2021: Sample Self Collection Kits, Nasal Swabs Maintain Market Dominance, Saliva Sampling Gains Popularity, Alternative Sampling Innovations
Published: 2021-05-07 (Crawled : 18:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.44%
H: 1.36%
C: -0.58%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.82%
H: 0.54%
C: -0.68%
QDEL | News M | $39.09 2.17% 2.12% 1.1M
|
Health Technology
|
| O: -0.18%
H: 16.21%
C: 11.62%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.44%
H: 1.36%
C: -0.58%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -1.03%
H: 4.88%
C: 2.39%
covid saliva test
OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Published: 2021-03-01 (Crawled : 22:00) - globenewswire.com
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -0.54%
H: 4.82%
C: 0.73%
covid financial results results
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva TestThis is the Eighth EUA to Include a Self-Collection Device from DNA Genotek
Published: 2021-01-29 (Crawled : 13:00) - biospace.com/
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -0.07%
H: 7.77%
C: 4.67%
covid test genetic
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test
Published: 2021-01-29 (Crawled : 11:01) - globenewswire.com
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -0.07%
H: 7.77%
C: 4.67%
covid test genetic
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing
Published: 2021-01-28 (Crawled : 11:03) - globenewswire.com
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.5%
H: 6.23%
C: 4.3%
covid test device authorized
OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program
Published: 2021-01-26 (Crawled : 13:00) - globenewswire.com
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 2.09%
H: 0.14%
C: -3.54%
covid test travel
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.